Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Genome Editing/Genome Engineering market report explains the definition, types, applications, major countries, and major players of the Genome Editing/Genome Engineering market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Transposagen Biopharmaceuticals
Lonza
Origene Technologies
Genscript
Crispr Therapeutics
Integrated Dna Technologies
Editas Medicine
Thermo Fisher Scientific
New England Biolabs
Sangamo Biosciences
Horizon Discovery
Merck
By Type:
CRISPR
TALEN
ZFN
By End-User:
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Genome Editing/Genome Engineering Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Genome Editing/Genome Engineering Outlook to 2028- Original Forecasts
-
2.2 Genome Editing/Genome Engineering Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Genome Editing/Genome Engineering Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Genome Editing/Genome Engineering Market- Recent Developments
-
6.1 Genome Editing/Genome Engineering Market News and Developments
-
6.2 Genome Editing/Genome Engineering Market Deals Landscape
7 Genome Editing/Genome Engineering Raw Materials and Cost Structure Analysis
-
7.1 Genome Editing/Genome Engineering Key Raw Materials
-
7.2 Genome Editing/Genome Engineering Price Trend of Key Raw Materials
-
7.3 Genome Editing/Genome Engineering Key Suppliers of Raw Materials
-
7.4 Genome Editing/Genome Engineering Market Concentration Rate of Raw Materials
-
7.5 Genome Editing/Genome Engineering Cost Structure Analysis
-
7.5.1 Genome Editing/Genome Engineering Raw Materials Analysis
-
7.5.2 Genome Editing/Genome Engineering Labor Cost Analysis
-
7.5.3 Genome Editing/Genome Engineering Manufacturing Expenses Analysis
8 Global Genome Editing/Genome Engineering Import and Export Analysis (Top 10 Countries)
-
8.1 Global Genome Editing/Genome Engineering Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Genome Editing/Genome Engineering Export by Region (Top 10 Countries) (2017-2028)
9 Global Genome Editing/Genome Engineering Market Outlook by Types and Applications to 2022
-
9.1 Global Genome Editing/Genome Engineering Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global CRISPR Consumption and Growth Rate (2017-2022)
-
9.1.2 Global TALEN Consumption and Growth Rate (2017-2022)
-
9.1.3 Global ZFN Consumption and Growth Rate (2017-2022)
-
9.2 Global Genome Editing/Genome Engineering Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cell Line Engineering Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Animal Genetic Engineering Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Plant Genetic Engineering Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Genome Editing/Genome Engineering Market Analysis and Outlook till 2022
-
10.1 Global Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.2.2 Canada Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.2.3 Mexico Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.3.2 UK Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.3.3 Spain Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.3.4 Belgium Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.3.5 France Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.3.6 Italy Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.3.7 Denmark Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.3.8 Finland Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.3.9 Norway Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.3.10 Sweden Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.3.11 Poland Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.3.12 Russia Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.3.13 Turkey Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.4.2 Japan Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.4.3 India Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.4.4 South Korea Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.4.5 Pakistan Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.4.6 Bangladesh Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.4.7 Indonesia Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.4.8 Thailand Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.4.9 Singapore Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.4.10 Malaysia Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.4.11 Philippines Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.4.12 Vietnam Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.5.2 Colombia Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.5.3 Chile Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.5.4 Argentina Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.5.5 Venezuela Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.5.6 Peru Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.5.7 Puerto Rico Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.5.8 Ecuador Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.6.2 Kuwait Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.6.3 Oman Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.6.4 Qatar Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.6.5 Saudi Arabia Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.6.6 United Arab Emirates Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.7.2 South Africa Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.7.3 Egypt Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.7.4 Algeria Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Genome Editing/Genome Engineering Consumption (2017-2022)
-
10.8.2 New Zealand Genome Editing/Genome Engineering Consumption (2017-2022)
11 Global Genome Editing/Genome Engineering Competitive Analysis
-
11.1 Transposagen Biopharmaceuticals
-
11.1.1 Transposagen Biopharmaceuticals Company Details
-
11.1.2 Transposagen Biopharmaceuticals Genome Editing/Genome Engineering Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Transposagen Biopharmaceuticals Genome Editing/Genome Engineering Main Business and Markets Served
-
11.1.4 Transposagen Biopharmaceuticals Genome Editing/Genome Engineering Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Lonza
-
11.2.1 Lonza Company Details
-
11.2.2 Lonza Genome Editing/Genome Engineering Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Lonza Genome Editing/Genome Engineering Main Business and Markets Served
-
11.2.4 Lonza Genome Editing/Genome Engineering Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Origene Technologies
-
11.3.1 Origene Technologies Company Details
-
11.3.2 Origene Technologies Genome Editing/Genome Engineering Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Origene Technologies Genome Editing/Genome Engineering Main Business and Markets Served
-
11.3.4 Origene Technologies Genome Editing/Genome Engineering Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Genscript
-
11.4.1 Genscript Company Details
-
11.4.2 Genscript Genome Editing/Genome Engineering Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Genscript Genome Editing/Genome Engineering Main Business and Markets Served
-
11.4.4 Genscript Genome Editing/Genome Engineering Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Crispr Therapeutics
-
11.5.1 Crispr Therapeutics Company Details
-
11.5.2 Crispr Therapeutics Genome Editing/Genome Engineering Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Crispr Therapeutics Genome Editing/Genome Engineering Main Business and Markets Served
-
11.5.4 Crispr Therapeutics Genome Editing/Genome Engineering Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Integrated Dna Technologies
-
11.6.1 Integrated Dna Technologies Company Details
-
11.6.2 Integrated Dna Technologies Genome Editing/Genome Engineering Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Integrated Dna Technologies Genome Editing/Genome Engineering Main Business and Markets Served
-
11.6.4 Integrated Dna Technologies Genome Editing/Genome Engineering Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Editas Medicine
-
11.7.1 Editas Medicine Company Details
-
11.7.2 Editas Medicine Genome Editing/Genome Engineering Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Editas Medicine Genome Editing/Genome Engineering Main Business and Markets Served
-
11.7.4 Editas Medicine Genome Editing/Genome Engineering Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Thermo Fisher Scientific
-
11.8.1 Thermo Fisher Scientific Company Details
-
11.8.2 Thermo Fisher Scientific Genome Editing/Genome Engineering Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Thermo Fisher Scientific Genome Editing/Genome Engineering Main Business and Markets Served
-
11.8.4 Thermo Fisher Scientific Genome Editing/Genome Engineering Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 New England Biolabs
-
11.9.1 New England Biolabs Company Details
-
11.9.2 New England Biolabs Genome Editing/Genome Engineering Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 New England Biolabs Genome Editing/Genome Engineering Main Business and Markets Served
-
11.9.4 New England Biolabs Genome Editing/Genome Engineering Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Sangamo Biosciences
-
11.10.1 Sangamo Biosciences Company Details
-
11.10.2 Sangamo Biosciences Genome Editing/Genome Engineering Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Sangamo Biosciences Genome Editing/Genome Engineering Main Business and Markets Served
-
11.10.4 Sangamo Biosciences Genome Editing/Genome Engineering Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Horizon Discovery
-
11.11.1 Horizon Discovery Company Details
-
11.11.2 Horizon Discovery Genome Editing/Genome Engineering Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Horizon Discovery Genome Editing/Genome Engineering Main Business and Markets Served
-
11.11.4 Horizon Discovery Genome Editing/Genome Engineering Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Merck
-
11.12.1 Merck Company Details
-
11.12.2 Merck Genome Editing/Genome Engineering Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Merck Genome Editing/Genome Engineering Main Business and Markets Served
-
11.12.4 Merck Genome Editing/Genome Engineering Product Portfolio
-
11.12.5 Recent Research and Development Strategies
12 Global Genome Editing/Genome Engineering Market Outlook by Types and Applications to 2028
-
12.1 Global Genome Editing/Genome Engineering Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global CRISPR Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global TALEN Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global ZFN Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Genome Editing/Genome Engineering Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Cell Line Engineering Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Animal Genetic Engineering Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Plant Genetic Engineering Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Genome Editing/Genome Engineering Market Analysis and Outlook to 2028
-
13.1 Global Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.2.2 Canada Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.2.3 Mexico Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.3.2 UK Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.3.3 Spain Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.3.4 Belgium Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.3.5 France Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.3.6 Italy Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.3.7 Denmark Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.3.8 Finland Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.3.9 Norway Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.3.10 Sweden Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.3.11 Poland Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.3.12 Russia Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.3.13 Turkey Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.4.2 Japan Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.4.3 India Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.4.4 South Korea Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.4.8 Thailand Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.4.9 Singapore Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.4.11 Philippines Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.5.2 Colombia Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.5.3 Chile Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.5.4 Argentina Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.5.6 Peru Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.6.3 Oman Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.6.4 Qatar Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.7.2 South Africa Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.7.3 Egypt Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.7.4 Algeria Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Genome Editing/Genome Engineering Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Genome Editing/Genome Engineering
-
Figure of Genome Editing/Genome Engineering Picture
-
Table Global Genome Editing/Genome Engineering Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Genome Editing/Genome Engineering Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global CRISPR Consumption and Growth Rate (2017-2022)
-
Figure Global TALEN Consumption and Growth Rate (2017-2022)
-
Figure Global ZFN Consumption and Growth Rate (2017-2022)
-
Figure Global Cell Line Engineering Consumption and Growth Rate (2017-2022)
-
Figure Global Animal Genetic Engineering Consumption and Growth Rate (2017-2022)
-
Figure Global Plant Genetic Engineering Consumption and Growth Rate (2017-2022)
-
Figure Global Genome Editing/Genome Engineering Consumption by Country (2017-2022)
-
Table North America Genome Editing/Genome Engineering Consumption by Country (2017-2022)
-
Figure United States Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Canada Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Mexico Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Table Europe Genome Editing/Genome Engineering Consumption by Country (2017-2022)
-
Figure Germany Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure UK Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Spain Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Belgium Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure France Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Italy Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Denmark Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Finland Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Norway Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Sweden Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Poland Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Russia Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Turkey Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Table APAC Genome Editing/Genome Engineering Consumption by Country (2017-2022)
-
Figure China Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Japan Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure India Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure South Korea Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Thailand Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Singapore Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Philippines Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Table South America Genome Editing/Genome Engineering Consumption by Country (2017-2022)
-
Figure Brazil Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Colombia Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Chile Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Argentina Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Peru Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Table GCC Genome Editing/Genome Engineering Consumption by Country (2017-2022)
-
Figure Bahrain Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Oman Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Qatar Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Table Africa Genome Editing/Genome Engineering Consumption by Country (2017-2022)
-
Figure Nigeria Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure South Africa Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Egypt Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure Algeria Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Table Oceania Genome Editing/Genome Engineering Consumption by Country (2017-2022)
-
Figure Australia Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Genome Editing/Genome Engineering Consumption and Growth Rate (2017-2022)
-
Table Transposagen Biopharmaceuticals Company Details
-
Table Transposagen Biopharmaceuticals Genome Editing/Genome Engineering Sales, Price, Value and Gross Profit (2017-2022)
-
Table Transposagen Biopharmaceuticals Genome Editing/Genome Engineering Main Business and Markets Served
-
Table Transposagen Biopharmaceuticals Genome Editing/Genome Engineering Product Portfolio
-
Table Lonza Company Details
-
Table Lonza Genome Editing/Genome Engineering Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lonza Genome Editing/Genome Engineering Main Business and Markets Served
-
Table Lonza Genome Editing/Genome Engineering Product Portfolio
-
Table Origene Technologies Company Details
-
Table Origene Technologies Genome Editing/Genome Engineering Sales, Price, Value and Gross Profit (2017-2022)
-
Table Origene Technologies Genome Editing/Genome Engineering Main Business and Markets Served
-
Table Origene Technologies Genome Editing/Genome Engineering Product Portfolio
-
Table Genscript Company Details
-
Table Genscript Genome Editing/Genome Engineering Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genscript Genome Editing/Genome Engineering Main Business and Markets Served
-
Table Genscript Genome Editing/Genome Engineering Product Portfolio
-
Table Crispr Therapeutics Company Details
-
Table Crispr Therapeutics Genome Editing/Genome Engineering Sales, Price, Value and Gross Profit (2017-2022)
-
Table Crispr Therapeutics Genome Editing/Genome Engineering Main Business and Markets Served
-
Table Crispr Therapeutics Genome Editing/Genome Engineering Product Portfolio
-
Table Integrated Dna Technologies Company Details
-
Table Integrated Dna Technologies Genome Editing/Genome Engineering Sales, Price, Value and Gross Profit (2017-2022)
-
Table Integrated Dna Technologies Genome Editing/Genome Engineering Main Business and Markets Served
-
Table Integrated Dna Technologies Genome Editing/Genome Engineering Product Portfolio
-
Table Editas Medicine Company Details
-
Table Editas Medicine Genome Editing/Genome Engineering Sales, Price, Value and Gross Profit (2017-2022)
-
Table Editas Medicine Genome Editing/Genome Engineering Main Business and Markets Served
-
Table Editas Medicine Genome Editing/Genome Engineering Product Portfolio
-
Table Thermo Fisher Scientific Company Details
-
Table Thermo Fisher Scientific Genome Editing/Genome Engineering Sales, Price, Value and Gross Profit (2017-2022)
-
Table Thermo Fisher Scientific Genome Editing/Genome Engineering Main Business and Markets Served
-
Table Thermo Fisher Scientific Genome Editing/Genome Engineering Product Portfolio
-
Table New England Biolabs Company Details
-
Table New England Biolabs Genome Editing/Genome Engineering Sales, Price, Value and Gross Profit (2017-2022)
-
Table New England Biolabs Genome Editing/Genome Engineering Main Business and Markets Served
-
Table New England Biolabs Genome Editing/Genome Engineering Product Portfolio
-
Table Sangamo Biosciences Company Details
-
Table Sangamo Biosciences Genome Editing/Genome Engineering Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sangamo Biosciences Genome Editing/Genome Engineering Main Business and Markets Served
-
Table Sangamo Biosciences Genome Editing/Genome Engineering Product Portfolio
-
Table Horizon Discovery Company Details
-
Table Horizon Discovery Genome Editing/Genome Engineering Sales, Price, Value and Gross Profit (2017-2022)
-
Table Horizon Discovery Genome Editing/Genome Engineering Main Business and Markets Served
-
Table Horizon Discovery Genome Editing/Genome Engineering Product Portfolio
-
Table Merck Company Details
-
Table Merck Genome Editing/Genome Engineering Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Genome Editing/Genome Engineering Main Business and Markets Served
-
Table Merck Genome Editing/Genome Engineering Product Portfolio
-
Figure Global CRISPR Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global TALEN Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ZFN Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cell Line Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Animal Genetic Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Plant Genetic Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Genome Editing/Genome Engineering Consumption Forecast by Country (2022-2028)
-
Table North America Genome Editing/Genome Engineering Consumption Forecast by Country (2022-2028)
-
Figure United States Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Genome Editing/Genome Engineering Consumption Forecast by Country (2022-2028)
-
Figure Germany Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Genome Editing/Genome Engineering Consumption Forecast by Country (2022-2028)
-
Figure China Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Genome Editing/Genome Engineering Consumption Forecast by Country (2022-2028)
-
Figure Brazil Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Genome Editing/Genome Engineering Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Genome Editing/Genome Engineering Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Genome Editing/Genome Engineering Consumption Forecast by Country (2022-2028)
-
Figure Australia Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Genome Editing/Genome Engineering Consumption Forecast and Growth Rate (2022-2028)
-
